The spatial-temporal relationship between the Aβ pathway and tau pathophysiology in AD, at both the molecular and macroscale, is critical to understanding AD pathogenesis and pathophysiological progression, and has gained momentum recently with the validation of several biomarkers charting different biological levels. The gene discussed is MAPT; the disease is Alzheimer disease.